Sign In
Buy BIIB
$197.19
-2.52 (-1.26%)
At Close: Jun 23, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
05:58pm, Tuesday, 23'rd Jun 2026
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB). Such investors are advised
Biogen To Acquire RayThera For Up To $1 Billion, Expanding Immunology Pipeline
11:07am, Thursday, 18'th Jun 2026
Biogen acquires RayThera in a deal worth up to $1 billion, adding early-stage immunology assets as it expands beyond Alzheimer's disease.
Biogen to Strengthen Immunology Pipeline With $1B RayThera Buyout
10:55am, Thursday, 18'th Jun 2026
BIIB is set to acquire RayThera for up to $1 billion, adding anti-inflammatory candidates that could expand its immunology pipeline and future growth.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
10:00am, Thursday, 18'th Jun 2026
NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB). Such investors are advised to contact D
Biogen to acquire RayThera for $1 billion
07:10pm, Wednesday, 17'th Jun 2026
Biogen said on Wednesday it would acquire drug discovery company RayThera for $1 billion, including milestone payments.
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
06:59pm, Wednesday, 17'th Jun 2026
Acquisition adds multiple immunology assets to Biogen's portfolio, including a lead asset poised to enter Phase 1 development Acquisition adds multiple immunology assets to Biogen's portfolio, includi
The Healthcare M&A Wave
12:30pm, Wednesday, 17'th Jun 2026
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
06:45pm, Tuesday, 16'th Jun 2026
NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB). Such investors are advised t
BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm
12:00pm, Thursday, 11'th Jun 2026
LOS ANGELES, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biogen Inc. ("Biogen"
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
10:00am, Thursday, 11'th Jun 2026
NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB). Such investors are advised to contact Da
Congresswoman Who Bought No Stocks In 2025 Is Back With More 2026 Trades: Here's The Shopping List
06:46pm, Wednesday, 10'th Jun 2026
After not buying or selling any stocks in 2025, a congresswoman who made over $2.4 million in trades in 2024 is buying stocks once again in 2026. Here's a look at the latest transactions.
BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm
10:29am, Wednesday, 10'th Jun 2026
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biogen Inc. (“B
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
01:42pm, Tuesday, 09'th Jun 2026
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB). Such investors are advised
This Biogen Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday
09:58am, Monday, 08'th Jun 2026
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm
09:00am, Monday, 08'th Jun 2026
LOS ANGELES, June 8, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biogen Inc. ("Biogen"
